What:  Luncheon with the Experts presented by the Carcinoid Cancer Foundation

Who:  Namrata (Neena) 
Vijayvergia, MD, is the featured guest

When:  Thursday, September 16, 2021 from 12 noon to 1 pm, Eastern Time

Where:  CCF’s Facebook Page, https://www.facebook.com/Carcinoid/. Just come to the page at noon and the program will begin. There is no need to register nor is there a special link.
For anyone not on Facebook, each of the presentations in the series is available on CCF’s YouTube channel, https://www.youtube.com/user/CarcinoidNETs. To receive notifications of all new videos on our YouTube channel, CLICK LIKE, SUBSCRIBE and HIT THE BELL to receive notifications each time a new video is uploaded.
CCF's Facebook page
Namrata (Neena) Vijayvergia, MD, medical oncologist, will be the featured guest for Facebook Live Luncheon with the Experts on Thursday, September 16, 2021. Dr. Vijayvergia is the Assistant Chief of Gastrointestinal Medical Oncology at Fox Chase Cancer Center in Philadelphia, Pennsylvania. Dr. Vijayvergia dedicates her practice to helping discover new therapies for patients with gastrointestinal cancers, with a particular focus on pancreatic and neuroendocrine malignancies.
Dr. Vijayvergia - medical oncologist at Fox Chase Cancer Center
Dr. Vijayvergia has been a faculty member at Fox Chase since 2015. Her mission is to advance patient-centric care with a focus on personalized medicine, patient-reported outcomes, and digital health technologies. She is actively involved in clinical as well as other research studies using federal, foundation, and industry grant support. Dr. Vijayvergia has led teams in the gastrointestinal program and as the medical director for medical oncology for the Fox Chase Partners program, as well as at the Temple University Hospital - Jeanes Campus hematology/oncology consult service.
In 2020 Dr. Vijayvergia was named a recipient of the 40 Under 40 in Cancer Award, which identifies and recognizes the contributions being made in cancer by emerging leaders.
powered by emma
Subscribe to our email list.